Pharmacovigilance & Drug Safety 2017

It is our great pleasure to announce the upcoming conference “9th International Conference and Exhibition on Pharmacovigilance & Drug Safety” during  July 17-18, 2017 in Munich, Germany is mainly focused on the new scientific and technical advances in the field of Pharmacovigilance & Clinical trials, Drug Safety, Regulatory Compliance Risk Management and most recent advancements in  Clinical research. It also focuses on the advancements in Pharmacovigilance, Risk Management and Data Quality Management. This conference is two full days of technical sessions and poster sessions on cutting edge tracks related to pharmaceutical sciences, there also many opportunities for networking and socializing with our colleagues.

Pharmacovigilance 2016 was held at Vienna in Austria  & received appreciable response and active participation from the scientists, researchers and leaders from clinical, government organizations and  students made this conference as one of the most successful and productive events in 2016.

U.S. pharmacovigilance market size was valued over USD 1 billion in 2015, and predicted to witness 10.7% CAGR from 2016 to 2024

Europe pharmacovigilance market size was valued over USD 793 million in 2015, with expectations to reach USD 1.8 billion by 2024,

This Conference is an excellent opportunity for the delegates from Universities, organizations and Institutes to interact with the world class Scientists. We cordially invite all the participants who are interested in sharing their knowledge and research in the area of Pharmacovigilance & Clinical trials, Drug Safety and Regulatory Compliance.

Pharmacovigilance 2017 anticipates participants around the globe with thought provoking Keynote lectures, Oral and Poster presentations. The attending delegates include Editorial Board Members of related International Journals.